News

December 18, 2008 - Abbott this week said it started the SPIRIT Small Vessel, a clinical trial evaluating a 2.25mm size ...

Home December 17, 2008
Home
News

December 18, 2008 - MiCardia announced the successful implant in two patients with the new new Dynaplasty mitral valve ...

Home December 17, 2008
Home
News

December 18, 2008 - Boston Scientific Corp. today announced enrollment of the first patient in the CABANA post-market ...

Home December 17, 2008
Home
News

December 18, 2008 - Spectranetics Corp. this week said the FDA cleared the Cross-Pilot Laser Support Catheter used in ...

Home December 17, 2008
Home
News

December 18, 2008 - ZOLL Medical Corp. this week received FDA 510(k) clearance to market and sell the ZOLL R Series Code ...

Home December 17, 2008
Home
News

December 17, 2008 – Yesterday’s agreement between Spacelabs Healthcare and Uscom gives Spacelabs exclusive distribution ...

Home December 16, 2008
Home
News

December 17, 2008 - Bioheart Inc. announced yesterday its plan to shift focus from several non-core technology platforms ...

Home December 16, 2008
Home
News

December 17, 2008 – In the latest MD Buyline survey, GE Healthcare Monitoring Solutions and Diagnostic Cardiology ...

Home December 16, 2008
Home
News

December 16, 2008 - Rcadia Medical Imaging Ltd., developer of the COR Analyzer software for the automated analysis of coronary CT angiography (CCTA) studies, closed a $3.3M investment round led by BioVentures Investors of Cambridge, MA.

Home December 16, 2008
Home
News

December 15, 2008 - The FDA has approved Abbott's TRILIPIX (fenofibric acid) delayed-release capsules, the first and ...

Home December 15, 2008
Home
News

December 16, 2008 – Digisonics was awarded the Best in KLAS for the cardiology market segment in the 2008 Top 20 Best in ...

Home December 15, 2008
Home
News

December 16, 2008 - New data from a retrospective, multicenter, cohort study of over four million hospitalized patients ...

Home December 15, 2008
Home
News

December 15, 2008 - Lantheus Medical Imaging reported that new data from a retrospective, multicenter, cohort study of over four million hospitalized patients showed similar unadjusted mortality rates for patients receiving DEFINITY Vial for (Perflutren Lipid Microsphere) Injectable Suspension enhanced resting echocardiography exams when compared with patients who did not receive DEFINITY.

Home December 15, 2008
Home
News

December 15, 2008 - Visage Imaging Inc. has received FDA 510(k) clearance to market its latest thin-client product ...

Home December 14, 2008
Home
News

December 15, 2008 - Terumo Corp. and its subsidiary, Terumo Cardiovascular Systems Corp., announced they have entered ...

Home December 14, 2008
Home
Subscribe Now